Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
EBITDA Margin
83.27%
Quarterly · Period ending:
BIO EBITDA Margin
Latest reported83.27%period ending
Latest reported83.27%period ending
BIO Quarterly EBITDA Margin (100.00% → 83.27%)
Quarterly ebitda margin
High-resolution chart · PNG
BIO ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 83.2719% | |
| -107.5156% | |
| 141.9215% | |
| -57.366% | |
| 71.7004% | |
| 22.8049% | |
| -126.9561% | |
| 140.473% | |
| -428.7737% | |
| 88.4802% | |
| 70.165% | |
| 29.5512% | |
| -213.2231% | |
| 19.6155% | |
| 156.5088% | |
| -23.7008% | |
| -170.0748% | |
| -618.6001% | |
| -273.482% | |
| 676.8434% | |
| 166.3342% | |
| 183.0364% | |
| 141.7296% | |
| 266.3197% | |
| 239.6038% | |
| 164.0862% | |
| 113.5109% | |
| -52.7959% | |
| 141.2182% | |
| 210.5047% | |
| -162.031% | |
| 71.7424% | |
| 66.0628% | |
| 163.8694% | |
| 13.8352% | |
| 14.9068% | |
| 8.7513% | |
| 11.7764% | |
| 1.6887% | |
| 13.1323% | |
| 13.5598% | |
| 12.7049% | |
| 16.486% | |
| 13.788% | |
| 15.1155% | |
| 14.3363% | |
| 15.131% | |
| 13.3753% | |
| 16.8949% | |
| 11.3485% | |
| 15.5232% | |
| 13.2052% | |
| 18.2039% | |
| 13.6718% | |
| 18.5536% | |
| 19.8598% | |
| 21.5651% | |
| 18.6048% | |
| 21.585% | |
| 19.0698% | |
| 19.0716% | |
| 19.1997% | |
| 19.9889% | |
| 20.9204% | |
| 20.4772% | |
| 20.2123% | |
| 11.4036% | |
| 19.9423% | |
| 19.9163% | |
| 18.3021% | |
| 8.2803% | |
| 17.1466% | |
| 17.9175% | |
| 17.9724% | |
| 11.8955% | |
| 15.3325% | |
| 14.7888% | |
| 16.5035% | |
| 13.078% | |
| 14.3439% | |
| 17.8412% | |
| 19.5688% | |
| 12.4668% | |
| 14.0846% | |
| 14.7071% | |
| 18.4697% | |
| 14.6472% | |
| 15.414% | |
| 17.7696% | |
| 17.6568% | |
| 16.7166% | |
| 17.9291% | |
| 19.1871% | |
| 21.9792% | |
| 18.0959% | |
| 20.3297% | |
| 19.3352% | |
| 21.0575% | |
| 19.306% | |
| 16.6574% |